*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Respiratory Syncytial Virus (RSV) Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global respiratory syncytial virus (RSV) diagnostics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.

Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:

RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory syncytial virus (RSV) diagnostics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and end use.

Breakup by Product:

  • Direct Fluorescent Antibody (DFA) Method
  • Rapid Antigen Diagnostic Test (RADTs)
  • Molecular Diagnostics
  • Chromatographic Immunoassay
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others
     

Breakup by End Use:

  • Hospitals and Clinics
  • Laboratory
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation, Thermo Fisher Scientific Inc.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Product, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation, Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Respiratory Syncytial Virus (RSV) Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Direct Fluorescent Antibody (DFA) Method
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Rapid Antigen Diagnostic Test (RADTs)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Molecular Diagnostics
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Chromatographic Immunoassay
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Diagnostic Imaging
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Gel Microdroplets
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Flow Cytometry
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Others
        6.8.1 Market Trends
        6.8.2 Market Forecast
7    Market Breakup by End Use
    7.1    Hospitals and Clinics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Laboratory
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbott Laboratories
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Becton, Dickinson and Company
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    bioMérieux SA
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bio-Rad Laboratories Inc. 
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Coris BioConcept
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
        13.3.6    DiaSorin Molecular LLC (DiaSorin Inc)
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
        13.3.7    F. Hoffmann-La Roche AG
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 SWOT Analysis
        13.3.8    Merck KGaA
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Quest Diagnostics Incorporated
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Quidel Corporation
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Thermo Fisher Scientific Inc.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials
           13.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2020
Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2020
Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2020
Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody (DFA) Method) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody (DFA) Method) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test (RADTs)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test (RADTs)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2020
Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links